Clinical Trials in Austin

Showing 7041-7060 of 11,561 trials

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

NCT03731052

This Phase 3 study (Study 307) has been designed to determine and compare the efficacy and safety of 188-0551 Spray and Vehicle Spray applied twice daily for up to four weeks in subjects with plaque psoriasis. Subjects will be instructed to apply the test article (188-0551 Spray or Vehicle Spray) to all psoriasis plaques within the designated Treatment Area twice daily for four weeks (Study Day 29), unless the investigator verifies the subject's psoriasis has cleared at Day 15, then test article application will be for 2 weeks (Study Day 15).

Plaque Psoriasis

Therapeutics, Inc.217 participantsStarted Oct 2018

Los Angeles, California, United States • Ocala, Florida, United States • Macon, Georgia, United States +11 more locations

COMPLETEDPhase 1< 1 mile

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

NCT02858401

The primary objectives of this study are to evaluate the safety and tolerability of escalating, multiple doses of vesatolimod (formerly GS-9620) in HIV-1 infected virologically suppressed adults on antiretroviral therapy (ART) and to evaluate the virologic effect of vesatolimod as measured by changes in plasma HIV-1 RNA.

HIV-1 Infection

Gilead Sciences48 participantsStarted Jan 2015

Los Angeles, California, United States • San Diego, California, United States • Ft. Pierce, Florida, United States +5 more locations

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

Safety and Biological Activity of Vesatolimod in HIV-1 Infected, Virologically Suppressed Adults

Find Trials by Condition in Austin

Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Ketoprofen Topical Patch, 20% in the Treatment of Pain Associated With Osteoarthritis Flare of the Knee

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

ANG1005 in Patients With Recurrent High-Grade Glioma

A Phase 3 Study of Tanezumab for Chronic Low Back Pain

An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

In-Home Assessment of a Smart Foot Mat for Prevention of Diabetic Foot Ulcers

Mitroflow DL Post Approval Study- North America